At school from Simg to manage the new drugs

«For many years, pharmaceutical companies have rejected the principle that medical-scientific information should be addressed to all family doctors, regardless of the treatment plan. I hope that they will now collaborate with us rather than become champions of medical-scientific information on their own".

DOMENICA 16 NOVEMBRE 2014 – healthesk

Dal prossimo dicembre i medici di famiglia andranno a scuola per imparare a gestire i farmaci più innovativi che sono già o che stanno arrivando sul mercato. Non tutti, però: per ora saranno 2 mila, selezionati tra quelli che hanno aderito al progetto dell’Aifa, l’Agenzia italiana del farmaco, che permetterà loro di prescrivere i medicinali sottoposti a Piano terapeutico, finora prescrivibili solo dai medici specialisti.

«For many years – he underlines Claudio Cricelli, presidente della Simg, la Società italiana di medicina generale – i farmaci innovativi sottoposti al Piano terapeutico non sono oggetto di informazione scientifica rivolta ai medici di Medicina generale. Ma questa situazione è destinata a cambiare radicalmente».

Cricelli ricorda che la Società scientifica ha «sostenuto con forza» il progetto dell’Aifa e ora «vogliamo offrire opportunità formative ai medici di famiglia». Per questo ha deciso di creare, all’interno of the high school of Simg, the first high school of medicine. «Pharmaceutical companies – says Cricelli – for many years have rejected the principle that medical-scientific information should be addressed to all family doctors, regardless of the treatment plan. I hope that they will now collaborate with us rather than become champions of medical-scientific information on their own". The president of Simg explains that the School will provide training "directly" to its professionals and will not limit itself to the content of the leaflet, but will teach the management of the drug within the complexity of the treatment process. The Aifa project «is the recognition of the great ability of general medicine to appropriately manage each drug. The school represents an indispensable tool for the management training of white coats. For too many years, even without knowledge of new drugs and their side effects, we have taken care of patients who were prescribed these drugs by specialists. And we have not shirked our responsibilities. Simg - concludes Cricelli - has tried to make up for these problems, guaranteeing in any case training for family doctors".